These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33488358)

  • 1. Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease.
    Hector A; Brouillette J
    Front Mol Neurosci; 2020; 13():600084. PubMed ID: 33488358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats.
    Hector A; Provost C; Delignat-Lavaud B; Bouamira K; Menaouar CA; Mongrain V; Brouillette J
    Alzheimers Res Ther; 2023 Oct; 15(1):174. PubMed ID: 37833786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps.
    Sajadi A; Provost C; Pham B; Brouillette J
    J Vis Exp; 2016 Aug; (114):. PubMed ID: 27585306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    Watremez W; Jackson J; Almari B; McLean SL; Grayson B; Neill JC; Fischer N; Allouche A; Koziel V; Pillot T; Harte MK
    J Alzheimers Dis; 2018; 62(1):213-226. PubMed ID: 29439327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic removal of synaptic Zn
    Vogler EC; Mahavongtrakul M; Sarkan K; Bohannan RC; Catuara-Solarz S; Busciglio J
    Front Neurol; 2022; 13():882635. PubMed ID: 36742045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways.
    Morroni F; Sita G; Tarozzi A; Rimondini R; Hrelia P
    Behav Brain Res; 2016 Nov; 314():106-15. PubMed ID: 27498145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo.
    Kim HG; Moon M; Choi JG; Park G; Kim AJ; Hur J; Lee KT; Oh MS
    Neurotoxicology; 2014 Jan; 40():23-32. PubMed ID: 24189446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
    Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
    J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairments of neural circuit function in Alzheimer's disease.
    Busche MA; Konnerth A
    Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic insights into early-stage Alzheimer's disease: Identifying key neuronal proteins impacted by amyloid beta oligomers in an in vitro model.
    Singh R; Joshi A; Koundal M; Sabharwal A; Verma N; Gahalot D; Sunkaria A
    Neuroscience; 2024 Nov; 560():254-262. PubMed ID: 39362622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bombycis excrementum reduces amyloid-β oligomer-induced memory impairments, neurodegeneration, and neuroinflammation in mice.
    Moon M; Choi JG; Kim SY; Oh MS
    J Alzheimers Dis; 2014; 41(2):599-613. PubMed ID: 24898636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.
    Ferreira ST; Lourenco MV; Oliveira MM; De Felice FG
    Front Cell Neurosci; 2015; 9():191. PubMed ID: 26074767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
    Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
    J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease.
    Brouillette J
    Curr Pharm Des; 2014; 20(15):2506-19. PubMed ID: 23859546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.